Volume 62 • 2001 • Supplement 27

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Introduction: Metabolic Disturbances Associated With Antipsychotic Use [Free]

J Clin Psychiatry 2001;62(suppl 27):3-4

Diagnosis, Classification, and Pathogenesis of Diabetes Mellitus

J Clin Psychiatry 2001;62(suppl 27):5-9

Clinical Experience With Insulin Resistance, Diabetic Ketoacidosis, and Type 2 Diabetes Mellitus in Patients Treated With Atypical Antipsychotic Agents

J Clin Psychiatry 2001;62(suppl 27):10-14

Hyperglycemia and Antipsychotic Medications

J Clin Psychiatry 2001;62(suppl 27):15-26

Effects of Atypical Antipsychotics on Weight and Serum Lipid Levels

J Clin Psychiatry 2001;62(suppl 27):27-34

Putting Metabolic Side Effects Into Perspective: Risks Versus Benefits of Atypical Antipsychotics

J Clin Psychiatry 2001;62(suppl 27):35-39

Concluding Discussion: Metabolic Disturbances Associated With Antipsychotics

J Clin Psychiatry 2001;62(suppl 27):40-41